Bystolic

Pharma

AbbVie escapes antitrust claims over blood pressure med Bystolic

AbbVie and a slate of generic drugmakers won a reprieve against claims they conspired to block generics of the blood pressure med Bystolic in the U.S.

Fraiser Kansteiner Jan 26, 2022 9:24am

Hey, doc, how about a burger with a side of branded drug scripts?

Jun 21, 2016 7:51am